Botanical species · safety record

Chionanthus virginicus

The EFSA Compendium of Botanicals holds 4 constituent measurements for Chionanthus virginicus. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Chionanthus virginicus L.

4Constituent measurements

0Safety records

2Cited sources

65Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 65 licensed products naming Chionanthus virginicus as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Source material stated

Aged bark
Bark
Branch bark
Chionanthus virginicus - root bark
Fresh root bark and adherent secondary roots
Needles
Root
Root bark

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Lignans	Roots and other underground parts	Solvent extraction	—	HPLC with standard detection methods	Resolve DOI
Phillyrin	Roots and other underground parts	Solvent extraction	≤ 1.79 Percent	HPLC with standard detection methods	Resolve DOI
Phillyrin	Roots and other underground parts	Solvent extraction	≥ 1.19 Percent	HPLC with standard detection methods	Resolve DOI
Saponins	Roots and other underground parts	Solvent extraction	—	Unspecified	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Boyer, L., Elias, R., Taoubi, K., Debrauwer, L., Faure, R., Baghdikian, B., Balansard, G. Lignans and secoiridoids from the root bark of Chionanthus virginicus L.: Isolation, identification and HPLC analysis. PHYTOCHEMICAL ANALYSIS, 2005, vol. 16, no. 5, p. 375-379. DOI
Youngken, H. W., Feldman, H. S. The pharmacognosy of Chionanthus. Journal of the american pharmaceutical association, None, p. 129-135.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature